The Canadian stocks we have uncovered have revenue growth over the past year that may seem unbelievable
SmallCapPower | August 1, 2018: With so many new companies entering the market, it can be hard to tell which have consumer demand. The Canadian stocks on our list today have recently begun ramping up sales, with average one-year revenue growth of 2670%, demonstrating a proof-of-concept. While we don’t foresee such robust levels of growth being replicated, all of these companies expect to continue growing at a rapid pace.
Nova Leap Health Corp. (TSXV:NLH) – $0.27
Investment Management & Fund Operators
Nova Leap Health is a North American provider of personal home care and support services. The Company is focused on acquiring and organically growing Private Pay Non-Medical and Skilled Home Care Companies. Nova Leap’s post-acquisition organic growth strategy is to increase annual revenue per location through a combination of increased employee investment, including training, focused sales and marketing efforts, billing rate increases and expansion of geographical coverage. Since October 2016, the Company has completed five acquisitions and now has operations in 6 locations within Vermont, New Hampshire, Rhode Island, Massachusetts, and Nova Scotia employing more than 450 employees. The Company is currently projected to generate $11M in annualized recurring revenue in FY2019.
- Market Cap: $15.6M
- Revenue FY2016: 53,706.57
- Revenue FY2017: 1,332,973.35
- 1-Year Revenue Growth: 2382.0%
- YTD Total Return: 31.7%
Avivagen Inc. (TSXV:VIV) – $0.66
Biotechnology & Medical Research
Avivagen is a Canada-based technology company advancing its OxC-beta technology. β-carotene, a micronutrient containing Vitamin A found in traditional livestock feeds, is now generally replaced with synthetic Vitamin A, but trials have found that β-carotene contains additional health benefits. OxC-beta is an antibiotic-free feed alternative containing β-carotene. The Company is currently licensed to sell in the Philippines, Taiwan, and Thailand, and is currently pursuing licensing in the U.S. and other Asian countries. VIV is also developing animal health supplements under its Vivamune Health Chews brand, with U.S. and Taiwanese distribution agreements.
- Market Cap: $20.9M
- Revenue FY2016: 10,560.00
- Revenue FY2017: 255,660.00
- 1-Year Revenue Growth: 2321.0%
- YTD Total Return: -26.7%
Isodiol International Inc. (CSE:ISOL) – $3.30
Isodiol International specializes in the production of pharmaceutical and consumer products with a focus on cannabidiol (CBD) nutraceuticals that are derived from hemp. Isodiol manufactures over 30 different products using 99.5%+ purity pharmaceutical grade cannabinoids and distributes domestically and globally. The Company has a diverse product portfolio, including nutraceuticals, clinically proven anti-aging skin care and beverages.
- Market Cap: $117.7M
- Revenue FY2016: 355,960.00
- Revenue FY2017: 19,137,270.00
- 1-Year Revenue Growth: 5276.2%
- YTD Total Return: -75.0%
Ecolomondo Corp. (TSXV:ECM) – $0.34
Corporate Financial Services
Ecolomondo is a Canada-based technology company focused on reprocessing waste feedstock into oil & gas, carbon black, and steel. The Thermal Decomposition (TDP) technology uses an automated rotary reactor to convert materials such as tires, diapers, shingles and plastics into gaseous hydrocarbons, with solid by-products. It is then condensed and separated into gas and oil, the former of which can be used to power the reactor. A pilot plant in Quebec processed 6.5 tons of tire waste in under 8 hours. The Company plans to build a 50,000 sq. ft. designed to process ~13,000t of tires/year in Ontario.
- Market Cap: $61.6M
- Revenue FY2016: 8,550.00
- Revenue FY2017: 160,420.00
- 1-Year Revenue Growth: 1776.3%
- YTD Total Return: -10.5%
good natured Products Inc. (TSXV:GDNP) – $0.13
good natured Products is a Canada-based bioplastics company. The Company creates bioplastics products, aimed primarily at packaging, producing over 100 food packaging designs, 10 grades of rollstock sheets, and 30 home & business organizational products. GDNP’s business model is highly scalable, using outsourced supply chain partners to manufacture its products. The Company uses this model to take advantage of growing demand in the bioplastics sector, which has an estimated compound annual growth rate of 30%. The Company plans to expand its market reach through organic growth, and by acquiring relevant brands and companies. On April 23, the Company has signed a 3-year agreement to supply a U.S. industry leader in thermoformed packaging. This deal is expected to generate US$1M in organic growth in FY2018.
- Market Cap: $12.7
- Revenue FY2016: 146,040.00
- Revenue FY2017: 2,478,960.00
- 1-Year Revenue Growth: 1597.5%
- YTD Total Return: 44.4%
Ubika Research/SmallCapPower has received compensation from good natured Products, Nova Leap Health, Isodiol International to provide analyst research coverage. For full disclosure please visit here >>.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below: